PL378400A1 - Zastosowanie nowego polimorfizmu w genie hsgk1 do diagnozowania nadciśnienia i zastosowanie rodziny genów sgk do diagnozowania i leczenia zespołu wydłużonego Q/T - Google Patents
Zastosowanie nowego polimorfizmu w genie hsgk1 do diagnozowania nadciśnienia i zastosowanie rodziny genów sgk do diagnozowania i leczenia zespołu wydłużonego Q/TInfo
- Publication number
- PL378400A1 PL378400A1 PL378400A PL37840004A PL378400A1 PL 378400 A1 PL378400 A1 PL 378400A1 PL 378400 A PL378400 A PL 378400A PL 37840004 A PL37840004 A PL 37840004A PL 378400 A1 PL378400 A1 PL 378400A1
- Authority
- PL
- Poland
- Prior art keywords
- diagnosis
- gene
- hypertonia
- syndrome
- therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Analytical Chemistry (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Wood Science & Technology (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10305213A DE10305213A1 (de) | 2003-02-07 | 2003-02-07 | Verwendung eines neuen Polymorphismus im hsgk1-Gen zur Diagnose der Hypertonie und Verwendung der sgk-Genfamilie zur Diagnose und Therapie des Long-Q/T-Syndroms |
Publications (1)
Publication Number | Publication Date |
---|---|
PL378400A1 true PL378400A1 (pl) | 2006-04-03 |
Family
ID=32747646
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL378400A PL378400A1 (pl) | 2003-02-07 | 2004-02-05 | Zastosowanie nowego polimorfizmu w genie hsgk1 do diagnozowania nadciśnienia i zastosowanie rodziny genów sgk do diagnozowania i leczenia zespołu wydłużonego Q/T |
Country Status (14)
Country | Link |
---|---|
US (1) | US20080015141A1 (pl) |
EP (1) | EP1594983A2 (pl) |
JP (1) | JP2006520587A (pl) |
KR (1) | KR20050118672A (pl) |
CN (1) | CN1761760A (pl) |
AU (1) | AU2004209609A1 (pl) |
BR (1) | BRPI0407292A (pl) |
CA (1) | CA2515339A1 (pl) |
DE (1) | DE10305213A1 (pl) |
MX (1) | MXPA05008329A (pl) |
PL (1) | PL378400A1 (pl) |
RU (1) | RU2005127807A (pl) |
WO (1) | WO2004070057A2 (pl) |
ZA (1) | ZA200506283B (pl) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5071998B2 (ja) * | 2005-08-25 | 2012-11-14 | 学校法人日本大学 | 本態性高血圧症の判定方法 |
WO2007025792A1 (de) * | 2005-09-02 | 2007-03-08 | Florian Lang | Verfahren zur diagnose von hypertonie |
EP2090588A4 (en) | 2006-10-23 | 2010-04-07 | Neocodex S L | IN VITRO PROCEDURE FOR THE PROGNOSIS AND / OR DIAGNOSIS OF OVER SENSITIVITY TO ESTROGENIC OR SUBSTANCES WITH ESTROGENIC EFFECT |
AR066984A1 (es) | 2007-06-15 | 2009-09-23 | Novartis Ag | Inhibicion de la expresion de la subunidad alfa del canal epitelial de sodio (enac) por medio de arni (arn de interferencia) |
CN101892311B (zh) * | 2010-06-01 | 2013-02-27 | 首都医科大学附属北京安贞医院 | 高血压易感基因的单核苷酸多态性位点rs7550536的检测方法及检测试剂盒 |
EP3049085B9 (en) * | 2013-09-26 | 2021-08-18 | Beth Israel Deaconess Medical Center, Inc. | Sgk1 inhibitors in the treatment of long qt syndrome |
TN2019000308A1 (en) | 2017-07-06 | 2021-05-07 | Arrowhead Pharmaceuticals Inc | RNAi AGENTS FOR INHIBITING EXPRESSION OF ALPHA-ENaC AND METHODS OF USE |
KR101992796B1 (ko) * | 2018-02-19 | 2019-06-26 | 한국 한의학 연구원 | Sgk1 유전자의 메틸화 수준을 이용한 고혈압의 예측 또는 진단을 위한 정보제공방법 및 이를 위한 조성물 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5474796A (en) * | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
ATE373676T1 (de) * | 1998-12-14 | 2007-10-15 | Univ Dundee | Verfahren zur aktivierung von sgk durch phosphorylierung. |
DE10113876A1 (de) * | 2001-03-21 | 2002-09-26 | Eberhard Karls Uni Medizinisch | Quantitative diagnostische Analyse der Hypertonie |
DE10225844A1 (de) * | 2002-06-04 | 2003-12-18 | Lang Florian | sgk und nedd als diagnostische und therapeutische targets |
-
2003
- 2003-02-07 DE DE10305213A patent/DE10305213A1/de not_active Withdrawn
-
2004
- 2004-02-05 MX MXPA05008329A patent/MXPA05008329A/es unknown
- 2004-02-05 EP EP04708317A patent/EP1594983A2/de not_active Withdrawn
- 2004-02-05 BR BR0407292-8A patent/BRPI0407292A/pt not_active IP Right Cessation
- 2004-02-05 CN CNA2004800070352A patent/CN1761760A/zh active Pending
- 2004-02-05 CA CA002515339A patent/CA2515339A1/en not_active Abandoned
- 2004-02-05 KR KR1020057014578A patent/KR20050118672A/ko not_active Application Discontinuation
- 2004-02-05 US US10/544,576 patent/US20080015141A1/en not_active Abandoned
- 2004-02-05 JP JP2006501739A patent/JP2006520587A/ja active Pending
- 2004-02-05 AU AU2004209609A patent/AU2004209609A1/en not_active Abandoned
- 2004-02-05 PL PL378400A patent/PL378400A1/pl not_active Application Discontinuation
- 2004-02-05 RU RU2005127807/13A patent/RU2005127807A/ru not_active Application Discontinuation
- 2004-02-05 WO PCT/EP2004/001051 patent/WO2004070057A2/de active Search and Examination
-
2005
- 2005-08-05 ZA ZA200506283A patent/ZA200506283B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2515339A1 (en) | 2004-08-19 |
US20080015141A1 (en) | 2008-01-17 |
MXPA05008329A (es) | 2005-09-30 |
WO2004070057A3 (de) | 2004-11-25 |
EP1594983A2 (de) | 2005-11-16 |
CN1761760A (zh) | 2006-04-19 |
ZA200506283B (en) | 2006-05-31 |
KR20050118672A (ko) | 2005-12-19 |
JP2006520587A (ja) | 2006-09-14 |
DE10305213A1 (de) | 2004-08-26 |
AU2004209609A1 (en) | 2004-08-19 |
WO2004070057A2 (de) | 2004-08-19 |
BRPI0407292A (pt) | 2006-01-31 |
RU2005127807A (ru) | 2006-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2406925B (en) | Facilitating and authenticating transactions | |
IL172316A0 (en) | Novel compounds and their use in therapy | |
HK1078851A1 (en) | 2-Indolinone-monoethanesulphonate and the use thereof in preparing a pharmaceutical composition | |
IL173576A0 (en) | Use of polypeptides of the cupredoxin family in cancer therapy | |
GB0413730D0 (en) | A pharmaceutical composition and its use | |
IL179795A0 (en) | A pharmaceutical composition and its use | |
IL172507A0 (en) | New biological entities and the pharmaceutical or diagnostic use thereof | |
TWI368509B (en) | Antituberculous therapeutic drugs and kit containing the same | |
EP1693005A4 (en) | ULTRASONIC UNIT AND ULTRASOUND SURVEY | |
EP1731547A4 (en) | POLYMERIZABLE COMPOUNDS AND USE THEREOF | |
EP1731524A4 (en) | PHENOLE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE DERIVATIVE, AND ITS MEDICINAL USE | |
IL178259A0 (en) | Novel benzothiazoles and the use thereof as medicaments | |
GB0523576D0 (en) | Drug composition and its use in therapy | |
PL394604A1 (pl) | Pochodna winyloazacykloalkanowa, jej zastosowanie oraz kompozycja farmaceutyczna | |
ZA200703876B (en) | 2-amido -4-phenylthiazole derivatives, the preparation and therapeutic use thereof | |
PL378400A1 (pl) | Zastosowanie nowego polimorfizmu w genie hsgk1 do diagnozowania nadciśnienia i zastosowanie rodziny genów sgk do diagnozowania i leczenia zespołu wydłużonego Q/T | |
ZA200210316B (en) | Composition and its therapeutic use. | |
GB0303663D0 (en) | Assays and medical treatments | |
AU2003217421A1 (en) | Prostate specific genes and the use thereof in design or therapeutics | |
AU2003255544A8 (en) | Tumor specific oligosaccharide epitopes and use thereof | |
GB0326578D0 (en) | Cancer diagnosis and therapy | |
TWI365187B (en) | 7-azaindoles and the use thereof as therapeutic agents | |
IL185575A0 (en) | Benzoxazocines and their therapeutic use | |
GB0411257D0 (en) | Cassette and its use | |
AU2003240253A1 (en) | Polymorphisms in the human gene for htr3b and their use in diagnostic and therapeutic applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |